AddLife AB
STO:ALIF B
Relative Value
The Relative Value of one ALIF B stock under the Base Case scenario is 242.29 SEK. Compared to the current market price of 110 SEK, AddLife AB is Undervalued by 55%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ALIF B Competitors Multiples
AddLife AB Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SE |
AddLife AB
STO:ALIF B
|
13.4B SEK | 1.4 | 169.7 | 36.5 | 36.5 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.3B USD | 5.3 | 37.2 | 23.2 | 33.8 | ||
US |
Danaher Corp
NYSE:DHR
|
197.4B USD | 4.5 | 24.5 | 17.7 | 21.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
45B USD | 6.7 | 36.4 | 29.1 | 35 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.5B USD | 2.8 | 30.5 | 16.6 | 25.7 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | 64.6 | 34.1 | 49.1 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.5 | 19.4 | 28.5 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.3B USD | 8.5 | 41.5 | 28.3 | 31.4 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.1B USD | 3.2 | 38.2 | 17.2 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.7B USD | 8.4 | 43.4 | 30.1 | 36.5 | ||
US |
Waters Corp
NYSE:WAT
|
20.8B USD | 7.2 | 34.5 | 23.1 | 28.5 |